KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $36.6 million.

  • Idexx Laboratories' Depreciation & Amortization (CF) rose 730.67% to $36.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $140.2 million, marking a year-over-year increase of 1127.36%. This contributed to the annual value of $129.9 million for FY2024, which is 1307.83% up from last year.
  • Latest data reveals that Idexx Laboratories reported Depreciation & Amortization (CF) of $36.6 million as of Q3 2025, which was up 730.67% from $35.8 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Depreciation & Amortization (CF) ranged from a high of $36.6 million in Q3 2025 and a low of $25.1 million during Q1 2021
  • Its 5-year average for Depreciation & Amortization (CF) is $29.9 million, with a median of $28.7 million in 2022.
  • As far as peak fluctuations go, Idexx Laboratories' Depreciation & Amortization (CF) plummeted by 94.94% in 2023, and later soared by 1776.09% in 2024.
  • Idexx Laboratories' Depreciation & Amortization (CF) (Quarter) stood at $27.7 million in 2021, then rose by 3.7% to $28.7 million in 2022, then grew by 3.54% to $29.7 million in 2023, then increased by 13.35% to $33.7 million in 2024, then rose by 8.67% to $36.6 million in 2025.
  • Its last three reported values are $36.6 million in Q3 2025, $35.8 million for Q2 2025, and $34.1 million during Q1 2025.